Contralateral biopsy in the management of testicular cancer: what we have learned and what we need to improve

Andrology. 2015 Jan;3(1):99-101. doi: 10.1111/andr.12008.
No abstract available

Publication types

  • Congress
  • Editorial

MeSH terms

  • Biopsy*
  • Carcinoma in Situ / pathology*
  • Carcinoma in Situ / therapy
  • Humans
  • Male
  • Neoplasms, Germ Cell and Embryonal / pathology*
  • Neoplasms, Germ Cell and Embryonal / therapy
  • Patient Selection
  • Predictive Value of Tests
  • Prognosis
  • Risk Factors
  • Testicular Neoplasms / pathology*
  • Testicular Neoplasms / therapy